Healthcare provider profile · identity verified

Shwetha S Sequeira, MD

Internal Medicine · BOSTON, MA · NPI 1982867578

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	489	166
Amlodipine Besylate	Amlodipine Besylate	316	98
Lisinopril	Lisinopril	313	108
Levothyroxine Sodium	Levothyroxine Sodium	188	53
Omeprazole	Omeprazole	172	56
Metoprolol Succinate	Metoprolol Succinate	161	51
Losartan Potassium	Losartan Potassium	149	64
Simvastatin	Simvastatin	148	49
Trazodone Hcl	Trazodone Hcl	123	36
Gabapentin	Gabapentin	108	35
Hydrochlorothiazide	Hydrochlorothiazide	100	36
Tamsulosin Hcl	Tamsulosin Hcl	89	28
Lorazepam	Lorazepam	88	24
Metformin Hcl	Metformin Hcl	86	32
Pantoprazole Sodium	Pantoprazole Sodium	81	24
Sertraline Hcl	Sertraline Hcl	77	23
Albuterol Sulfate Hfa	Albuterol Sulfate	65	33
Atenolol	Atenolol	64	25
Rosuvastatin Calcium	Rosuvastatin Calcium	63	22
Eliquis	Apixaban	61	17
Oxycodone Hcl	Oxycodone Hcl	55	16
Metoprolol Tartrate	Metoprolol Tartrate	53	15
Furosemide	Furosemide	52	17
Pravastatin Sodium	Pravastatin Sodium	52	18
Jardiance	Empagliflozin	51	suppressed
Famotidine	Famotidine	48	13
Metformin Hcl Er	Metformin Hcl	47	17
Citalopram Hbr	Citalopram Hydrobromide	46	13
Fluoxetine Hcl	Fluoxetine Hcl	43	12
Pregabalin	Pregabalin	43	12
Carvedilol	Carvedilol	41	11
Alendronate Sodium	Alendronate Sodium	39	12
Allopurinol	Allopurinol	37	15
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Duloxetine Hcl	Duloxetine Hcl	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	16
Clonazepam	Clonazepam	34	11
Tramadol Hcl	Tramadol Hcl	32	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Valsartan	Valsartan	31	suppressed
Bupropion Xl	Bupropion Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Topiramate	Topiramate	25	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Lidocaine	Lidocaine	21	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	12
Donepezil Hcl	Donepezil Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Celecoxib	Celecoxib	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Ozempic	Semaglutide	17	suppressed
Prednisone	Prednisone	17	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	16
Spironolactone	Spironolactone	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Finasteride	Finasteride	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	12
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nystatin	Nystatin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Propranolol Hcl	Propranolol Hcl	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error